Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric Cancer
This document outlines an ongoing clinical trial evaluating a novel humanized ferritin-based near-infrared fluorescent probe to identify sen…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis [Phase 1]
This is a Phase 1 clinical trial evaluating Aldesleukin in combination with Nivolumab and standard chemotherapy for clinical stage IV gastri…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Sentinel Node Resection With or Without LECS After Noncurative ESD for EGC [NA]
This clinical trial will compare sentinel node resection with or without LECS after noncurative endoscopic submucosal dissection in patients…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community
A National Taiwan University Hospital-led study describes individually tailored precision prevention strategies for gastric and colorectal c…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Ongoing Stanford University clinical trial evaluating clinical and pathological aspects of upper gastrointestinal cancers, including stomach…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of INBRX-106 in combination with pembrolizumab for locally advanced or metastatic sol…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma [Phase 3]
This clinical trial update describes a Phase 3 study evaluating a triplet regimen of Osemitamab (TST001), pembrolizumab, and chemotherapy as…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: RCT of Mobile Apps & FitBit v. Usual Care [NA]
An ongoing randomized trial compares a mobile apps plus FitBit intervention to usual care in patients with pancreatic, gastric, liver, colon…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer [Phase 3]
A Phase 3 trial evaluating the feasibility of enhanced recovery after surgery without prophylactic abdominal drainage tubes in patients unde…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TST001 in advanced or metastatic solid tumors (Phase 1/2); the study is currently active and not recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC) [Phase 2]
Phase 2 trial investigating a quadruple combination of Iparomlimab, Tuvonralimab, Apatinib, and Irinotecan hydrochloride for advanced Alpha-…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer [Phase 2]
Phase 2 clinical trial update shows GEN-001 in combination with Avelumab for PD-L1 positive gastric cancer and gastroesophageal junction ade…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Establishment and Effectiveness Evaluation of a Training System for Confocal Laser Endomicroscopy
Completed clinical trial evaluating a training system for confocal laser endomicroscopy and its effectiveness for gastric-related conditions…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: The GAstric Precancerous Conditions Study
The GAstric Precancerous Conditions Study at Stanford is currently recruiting participants to study gastric precancerous conditions, includi…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 study of SGN-B6A in Chinese participants with advanced solid tumors has completed, reporting safety and preliminary activity acros…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer [Phase 2]
A Phase 2 clinical trial is currently recruiting to evaluate perioperative therapies for locally advanced unresectable gastric cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Outcome of Patients With Malignant Gastric Outlet Obstruction Undergoing Endoscopic Ultrasound-guided Gastroenterostomy or Enteral Metal Stenting
This clinical trial update reports on outcomes for patients with malignant gastric outlet obstruction treated with EUS-guided gastroenterost…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. [Phase 3]
A Phase 3 trial evaluating bemarituzumab added to chemotherapy and nivolumab versus chemotherapy and nivolumab in FGFR2b-overexpressing untr…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of trastuzumab deruxtecan and afatinib for HER2-low advanced gastric cancer is current…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma [Phase 1]
Phase 1 clinical trial evaluating Claudin 18.2-targeted CAR-T cells in unresectable/locally advanced or metastatic gastric, gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Intravital Microscopy in Human Solid Tumors [NA]
Mayo Clinic is conducting a clinical trial using intravital microscopy in multiple solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue
Clinical trial update on a novel ferritin-based near-infrared fluorescent probe to identify tumor margins in gastric tissue; the study is no…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]
This trial update reports that MT-4561 is being studied in multiple advanced solid tumors across Phase 1/Phase 2 and is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer [Phase 1]
Clinical trial update indicating a Phase 1 study of PIPAC (pressurized intraperitoneal aerosol chemotherapy) to treat peritoneal carcinomato…